The Massachusetts Alliance for Economic Development is a private, non- profit partnership of business, industry leaders, and government dedicated to fostering economic growth in the Commonwealth.
About Regenerative Medicine
A new frontier in healthcare, regenerative medicine utilizes living human cells to repair or replace body tissue damaged by injury, disease or even the natural aging process.
Regenerative medicine is a multidisciplinary field which brings together biology, medicine, and engineering to empower scientists to grow living cells, tissues and organs in the laboratory, and to safely implant them into the human body for the purposes of healing.
Like human skin, Apligraf contains two layers of living cells: an outer (or epidermal) layer of protective skin cells, and an inner (or dermal) layer of cells. When placed on a wound previously unresponsive to treatment, Apligraf plays an active role by providing cells and proteins that help promote healing. In multiple controlled clinical studies, Apligraf has been shown to be an effective and safe wound care treatment, superior to conventional treatments. It has been used to treat many thousands of patients and is covered extensively by Medicare, Medicaid and by 350 private payers in the U.S.
About Organogenesis, Inc.
Having pioneered the field, Massachusetts based Organogenesis, Inc. is a world leading regenerative medicine company focused in the areas of bio-active wound healing, bio-surgery and oral regeneration. Organogenesis delivers living tissue "on demand," and its mission is to bring the medical marvel of regenerative medicine products to patients and to standardize their use in everyday medical care.
The company recently established European headquarters located in
|SOURCE Organogenesis, Inc.|
Copyright©2008 PR Newswire.
All rights reserved